Annual Book Value:
$145.95M+$52.84M(+56.75%)Summary
- As of today, LXRX annual book value is $145.95 million, with the most recent change of +$52.84 million (+56.75%) on December 31, 2024.
- During the last 3 years, LXRX annual book value has risen by +$32.35 million (+28.48%).
- LXRX annual book value is now -50.95% below its all-time high of $297.57 million, reached on December 31, 2011.
Performance
LXRX Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Book Value:
$120.16M-$9.28M(-7.17%)Summary
- As of today, LXRX quarterly book value is $120.16 million, with the most recent change of -$9.28 million (-7.17%) on September 30, 2025.
- Over the past year, LXRX quarterly book value has dropped by -$58.35 million (-32.69%).
- LXRX quarterly book value is now -62.32% below its all-time high of $318.90 million, reached on March 31, 2010.
Performance
LXRX Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Book Value Formula
Book Value = Total Assets − Total Liabilities
LXRX Book Value Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +56.8% | -32.7% |
| 3Y3 Years | +28.5% | -16.6% |
| 5Y5 Years | +24.6% | +37.1% |
LXRX Book Value Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +56.8% | -58.4% | +36.5% |
| 5Y | 5-Year | -6.7% | +56.8% | -58.4% | +69.6% |
| All-Time | All-Time | -51.0% | +652.7% | -62.3% | +285.2% |
LXRX Book Value History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $120.16M(-7.2%) |
| Jun 2025 | - | $129.44M(+5.2%) |
| Mar 2025 | - | $123.03M(-15.7%) |
| Dec 2024 | $145.95M(+56.7%) | $145.95M(-18.2%) |
| Sep 2024 | - | $178.51M(-25.6%) |
| Jun 2024 | - | $239.98M(-16.9%) |
| Mar 2024 | - | $288.84M(+210.2%) |
| Dec 2023 | $93.11M(-20.5%) | $93.11M(-33.3%) |
| Sep 2023 | - | $139.51M(-25.1%) |
| Jun 2023 | - | $186.36M(+111.7%) |
| Mar 2023 | - | $88.05M(-24.8%) |
| Dec 2022 | $117.12M(+3.1%) | $117.12M(-18.7%) |
| Sep 2022 | - | $144.02M(+103.3%) |
| Jun 2022 | - | $70.83M(-23.6%) |
| Mar 2022 | - | $92.70M(-18.4%) |
| Dec 2021 | $113.60M(-27.4%) | $113.60M(-16.8%) |
| Sep 2021 | - | $136.60M(-0.5%) |
| Jun 2021 | - | $137.23M(-10.0%) |
| Mar 2021 | - | $152.55M(-2.4%) |
| Dec 2020 | $156.37M(+33.5%) | $156.37M(+78.4%) |
| Sep 2020 | - | $87.64M(+920.1%) |
| Jun 2020 | - | -$10.69M(-119.5%) |
| Mar 2020 | - | $54.78M(-53.2%) |
| Dec 2019 | $117.10M(+543.5%) | $117.10M(-28.9%) |
| Sep 2019 | - | $164.71M(+353.8%) |
| Jun 2019 | - | -$64.89M(-42.0%) |
| Mar 2019 | - | -$45.69M(-73.0%) |
| Dec 2018 | -$26.41M(-138.7%) | -$26.41M(+10.2%) |
| Sep 2018 | - | -$29.40M(-479.9%) |
| Jun 2018 | - | -$5.07M(-119.4%) |
| Mar 2018 | - | $26.19M(-49.7%) |
| Dec 2017 | $68.27M(-56.6%) | $52.10M(-33.5%) |
| Sep 2017 | - | $78.38M(-26.3%) |
| Jun 2017 | - | $106.31M(-21.0%) |
| Mar 2017 | - | $134.60M(-14.5%) |
| Dec 2016 | $157.40M(-44.9%) | $157.40M(-15.0%) |
| Sep 2016 | - | $185.18M(-14.8%) |
| Jun 2016 | - | $217.33M(-14.1%) |
| Mar 2016 | - | $252.88M(+27.8%) |
| Dec 2015 | $285.85M(+0.6%) | - |
| Sep 2015 | - | $197.94M(-14.5%) |
| Jun 2015 | - | $231.47M(-10.1%) |
| Mar 2015 | - | $257.61M(-9.3%) |
| Dec 2014 | $284.02M(+66.9%) | $284.02M(+265.0%) |
| Sep 2014 | - | $77.82M(-33.3%) |
| Jun 2014 | - | $116.67M(-17.1%) |
| Mar 2014 | - | $140.77M(-17.3%) |
| Dec 2013 | $170.16M(-36.2%) | $170.16M(-8.4%) |
| Sep 2013 | - | $185.71M(-13.7%) |
| Jun 2013 | - | $215.08M(-11.2%) |
| Mar 2013 | - | $242.21M(-9.2%) |
| Dec 2012 | $266.68M | $266.68M(+5.5%) |
| Sep 2012 | - | $252.76M(+3.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $244.90M(-9.0%) |
| Mar 2012 | - | $268.97M(-9.6%) |
| Dec 2011 | $297.57M(+20.5%) | $297.57M(+75.6%) |
| Sep 2011 | - | $169.48M(-12.7%) |
| Jun 2011 | - | $194.19M(-11.5%) |
| Mar 2011 | - | $219.32M(-11.2%) |
| Dec 2010 | $247.02M(+50.8%) | $247.02M(-8.1%) |
| Sep 2010 | - | $268.85M(-8.9%) |
| Jun 2010 | - | $295.04M(-7.5%) |
| Mar 2010 | - | $318.90M(+94.7%) |
| Dec 2009 | $163.79M(-11.7%) | $163.79M(+26.6%) |
| Sep 2009 | - | $129.42M(-12.0%) |
| Jun 2009 | - | $147.11M(-11.3%) |
| Mar 2009 | - | $165.82M(-10.6%) |
| Dec 2008 | $185.58M(-27.6%) | $185.58M(-7.1%) |
| Sep 2008 | - | $199.68M(-8.6%) |
| Jun 2008 | - | $218.46M(-8.1%) |
| Mar 2008 | - | $237.80M(-7.2%) |
| Dec 2007 | $256.30M(+199.8%) | $256.30M(-3.4%) |
| Sep 2007 | - | $265.39M(+232.0%) |
| Jun 2007 | - | $79.94M(+15.8%) |
| Mar 2007 | - | $69.00M(-19.3%) |
| Dec 2006 | $85.50M(-0.4%) | $85.50M(+56.5%) |
| Sep 2006 | - | $54.65M(-11.6%) |
| Jun 2006 | - | $61.85M(-19.6%) |
| Mar 2006 | - | $76.93M(-10.3%) |
| Dec 2005 | $85.80M(-29.4%) | $85.80M(+7.4%) |
| Sep 2005 | - | $79.85M(-15.0%) |
| Jun 2005 | - | $93.90M(-13.4%) |
| Mar 2005 | - | $108.40M(-10.9%) |
| Dec 2004 | $121.59M(-26.8%) | $121.59M(-0.3%) |
| Sep 2004 | - | $121.99M(-10.5%) |
| Jun 2004 | - | $136.30M(-10.8%) |
| Mar 2004 | - | $152.78M(-8.1%) |
| Dec 2003 | $166.22M(-2.2%) | $166.22M(-6.9%) |
| Sep 2003 | - | $178.49M(+27.2%) |
| Jun 2003 | - | $140.32M(-9.7%) |
| Mar 2003 | - | $155.32M(-8.6%) |
| Dec 2002 | $169.90M(-22.2%) | $169.90M(-6.1%) |
| Sep 2002 | - | $181.00M(-7.2%) |
| Jun 2002 | - | $195.13M(-5.6%) |
| Mar 2002 | - | $206.77M(-5.3%) |
| Dec 2001 | $218.37M(+5.2%) | $218.37M(-3.8%) |
| Sep 2001 | - | $226.96M(+16.1%) |
| Jun 2001 | - | $195.55M(-3.5%) |
| Mar 2001 | - | $202.54M(-2.5%) |
| Dec 2000 | $207.63M(-1.9%) | $207.63M(-2.2%) |
| Sep 2000 | - | $212.19M(+1.0%) |
| Jun 2000 | - | $210.07M(+999.4%) |
| Mar 2000 | - | -$23.36M |
| Dec 1999 | $211.71M(+933.7%) | - |
| Dec 1998 | $20.48M(+1160.7%) | - |
| Dec 1997 | -$1.93M(-470.8%) | - |
| Dec 1996 | $520.70K | - |
FAQ
- What is Lexicon Pharmaceuticals, Inc. annual book value?
- What is the all-time high annual book value for Lexicon Pharmaceuticals, Inc.?
- What is Lexicon Pharmaceuticals, Inc. annual book value year-on-year change?
- What is Lexicon Pharmaceuticals, Inc. quarterly book value?
- What is the all-time high quarterly book value for Lexicon Pharmaceuticals, Inc.?
- What is Lexicon Pharmaceuticals, Inc. quarterly book value year-on-year change?
What is Lexicon Pharmaceuticals, Inc. annual book value?
The current annual book value of LXRX is $145.95M
What is the all-time high annual book value for Lexicon Pharmaceuticals, Inc.?
Lexicon Pharmaceuticals, Inc. all-time high annual book value is $297.57M
What is Lexicon Pharmaceuticals, Inc. annual book value year-on-year change?
Over the past year, LXRX annual book value has changed by +$52.84M (+56.75%)
What is Lexicon Pharmaceuticals, Inc. quarterly book value?
The current quarterly book value of LXRX is $120.16M
What is the all-time high quarterly book value for Lexicon Pharmaceuticals, Inc.?
Lexicon Pharmaceuticals, Inc. all-time high quarterly book value is $318.90M
What is Lexicon Pharmaceuticals, Inc. quarterly book value year-on-year change?
Over the past year, LXRX quarterly book value has changed by -$58.35M (-32.69%)